The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
1. Advisory Committee on Medicines Schedule (ACMS #27) - Final decisions made pursuant to regulation 42ZCZR
Final decision in relation to 1,4-Dimethylpentylamine (DMPA)
Final decision
Pursuant to regulation 42ZCZR of the Regulations, a Delegate of the Secretary has made a final decision to confirm the interim decision and amend the current Poisons Standard in relation to 1,4-Dimethylpentylamine (DMPA) as follows:
Schedule 10 - New Entry
1,4-DIMETHYLPENTYLAMINE (DMPA).
Index - New Entry
1,4-DIMETHYLPENTYLAMINE (DMPA)
Schedule 10
Index - Amend Entry
ALKYLAMINES WITH STIMULANT PROPERTIES
cross reference: 1,3-dimethylbutylamine, DMBA, octodrine, 1-aminoisoheptane, DMHA, 1,5-dimethylhexylamine, 4‑methylhexane-2-amine, 1,3-dimethylamylamine, DMAA, 4-amino-2-methylpentane citrate (AMP citrate), 1,4-dimethylpentylamine, DMPA.
Schedule 10
Date of effect of the decision
1 February 2020.
Reasons for the final decision (including findings on material questions of fact)
I have made a final decision to confirm my interim decision to Schedule 1,4-dimethylpentylamine in Schedule 10 of the Poisons Standard. I note that no public submissions were received before the second closing date in response to the call for further submissions published on 12 September 2019 under regulation 42ZCZP of the Regulations.
Public submissions in response to the interim decision
No public submissions were received in response to the interim decision.